{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lake Forest",
      "state": "IL",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "70303",
      "recalling_firm": "Hospira Inc.",
      "address_1": "275 N Field Dr",
      "address_2": "",
      "postal_code": "60045-2579",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0969-2015",
      "product_description": "0.9% Sodium Chloride Injection, USP, 250 mL, Rx Only, Hospira Inc., Lake Forest, IL, 60045, USA, NDC 0409-7983-02",
      "product_quantity": "661,128 containers",
      "reason_for_recall": "Presence of Particulate Matter; Hospira has identified the particulate as a human hair, sealed in the bag at the additive port area.",
      "recall_initiation_date": "20150120",
      "center_classification_date": "20150423",
      "termination_date": "20170117",
      "report_date": "20150429",
      "code_info": "Lot #: 44-002-JT (the lot number may be followed by 01 to 99), Exp 08/01/2016",
      "more_code_info": ""
    }
  ]
}